New Business Partnership For Guiding Microchimerism to Transplant Diagnostics with DigitalTRACE™

Omixon is pleased to announce that we have been entered a new strategic partnership of JETA Molecular BV., based in Utrecht, The Netherlands, effective as of April 2022. This partnership will combine Omixon’s expertise as an international provider of disruptive transplant diagnostics solutions with JETA Molecular latest technological solutions...

 

Read more